A non-animal new approach methodology to test predict human blood toxicity like safety concerns
The hematopoietic system, like most biological systems in the body, is a stem cell system. The hematopoietic system is unique, however, in that it has the potential to produce multiple cell types, each with different functions, from a single stem cell. For all biological systems, the stem cell, or rather the stem cell compartment, which contains many different stages of stem cell primitiveness or maturity, is the foundation upon which all biological systems are built.
Avila AM, Bebenek I, Bonzo JA, Bourcier T, Davis Bruno KL, Carlson DB, Dubinion J, Elayan I, Harrouk W, Lee SL, Mendrick DL, Merrill JC, Peretz J, Place E, Saulnier M, Wange RL, Yao J, Zhao D, Brown PC. An FDA/CDER perspective on nonclinical testing strategies: Classical toxicology approaches and new approach methodologies (NAMs). Regul Toxicol Pharmacol. 2020 Jul;114:104662. doi: 10.1016/j.yrtph.2020.104662. Epub 2020 Apr 20. PMID: 32325112.
Mahalingaiah PK, Palenski T, Van Vleet TR. An In Vitro Model of Hematotoxicity: Differentiation of Bone Marrow-Derived Stem/Progenitor Cells into Hematopoietic Lineages and Evaluation of Lineage-Specific Hematotoxicity. Curr Protoc Toxicol. 2018 May;76(1):e45. doi: 10.1002/cptx.45. Epub 2018 Apr 30. PMID: 30040226.